28.05.2012
- Biotechnology company Amylin Pharmaceuticals has drawn initial bids from drugmakers Merck & Co and Sanofi, Bloomberg News reported on Friday, citing anonymous sources. The...
20.04.2012
- Watchdog group Public Citizen urged U.S. regulators to withdraw approval of Novo Nordisk's diabetes drug Victoza, saying it increases the risk of serious health problems like...
28.03.2012
- Shares of Amylin Pharmaceuticals rose as much as 51% on Wednesday after Bloomberg News reported the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers...
